Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia. (2020)
Attributed to:
Hepcidin and its Regulatory Pathways in Malaria and in Adaptive Immunity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood.2019003140
PubMed Identifier: 31899794
Publication URI: http://europepmc.org/abstract/MED/31899794
Type: Journal Article/Review
Volume: 135
Parent Publication: Blood
Issue: 8
ISSN: 0006-4971